292 related articles for article (PubMed ID: 30518397)
1. The natural polyphenol curcumin induces apoptosis by suppressing STAT3 signaling in esophageal squamous cell carcinoma.
Liu Y; Wang X; Zeng S; Zhang X; Zhao J; Zhang X; Chen X; Yang W; Yang Y; Dong Z; Zhu J; Xu X; Tian F
J Exp Clin Cancer Res; 2018 Dec; 37(1):303. PubMed ID: 30518397
[TBL] [Abstract][Full Text] [Related]
2. S1PR1 promotes proliferation and inhibits apoptosis of esophageal squamous cell carcinoma through activating STAT3 pathway.
Liu Y; Zhi Y; Song H; Zong M; Yi J; Mao G; Chen L; Huang G
J Exp Clin Cancer Res; 2019 Aug; 38(1):369. PubMed ID: 31438989
[TBL] [Abstract][Full Text] [Related]
3. Plumbagin inhibits the proliferation and survival of esophageal cancer cells by blocking STAT3-PLK1-AKT signaling.
Cao YY; Yu J; Liu TT; Yang KX; Yang LY; Chen Q; Shi F; Hao JJ; Cai Y; Wang MR; Lu WH; Zhang Y
Cell Death Dis; 2018 Jan; 9(2):17. PubMed ID: 29339720
[TBL] [Abstract][Full Text] [Related]
4. Dehydrocostus Lactone Induces Apoptosis and Cell Cycle Arrest through Regulation of JAK2/STAT3/PLK1 Signaling Pathway in Human Esophageal Squamous Cell Carcinoma Cells.
Yang G; Sheng B; Li R; Xu Q; Zhang L; Lu Z
Anticancer Agents Med Chem; 2022; 22(9):1742-1752. PubMed ID: 34353270
[TBL] [Abstract][Full Text] [Related]
5. [The inhibition effects of apatinib on cell proliferation, migration and apoptosis in esophageal carcinoma via Ras/Raf/MEK/ERK and JAK2/STAT3 pathways].
Feng Y; Zhou MY; Sun F; Kong Z; Wang J; Sun ZQ; Hu LJ; Wang JL; Hua Q; Yu JP
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):263-275. PubMed ID: 31014051
[No Abstract] [Full Text] [Related]
6. Combination treatment with highly bioavailable curcumin and NQO1 inhibitor exhibits potent antitumor effects on esophageal squamous cell carcinoma.
Mizumoto A; Ohashi S; Kamada M; Saito T; Nakai Y; Baba K; Hirohashi K; Mitani Y; Kikuchi O; Matsubara J; Yamada A; Takahashi T; Lee H; Okuno Y; Kanai M; Muto M
J Gastroenterol; 2019 Aug; 54(8):687-698. PubMed ID: 30737573
[TBL] [Abstract][Full Text] [Related]
7. Plumbagin, a natural naphthoquinone, inhibits the growth of esophageal squamous cell carcinoma cells through inactivation of STAT3.
Cao Y; Yin X; Jia Y; Liu B; Wu S; Shang M
Int J Mol Med; 2018 Sep; 42(3):1569-1576. PubMed ID: 29901084
[TBL] [Abstract][Full Text] [Related]
8. Dracorhodin perchlorate induces apoptosis and G2/M cell cycle arrest in human esophageal squamous cell carcinoma through inhibition of the JAK2/STAT3 and AKT/FOXO3a pathways.
Lu Z; Lu C; Li C; Jiao Y; Li Y; Zhang G
Mol Med Rep; 2019 Sep; 20(3):2091-2100. PubMed ID: 31322237
[TBL] [Abstract][Full Text] [Related]
9. LINC01535 promotes proliferation and inhibits apoptosis in esophageal squamous cell cancer by activating the JAK/STAT3 pathway.
Fang Y; Zhang S; Yin J; Shen YX; Wang H; Chen XS; Tang H
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3694-3700. PubMed ID: 32329845
[TBL] [Abstract][Full Text] [Related]
10. Periplogenin suppresses the growth of esophageal squamous cell carcinoma in vitro and in vivo by targeting STAT3.
Hu Y; Liu F; Jia X; Wang P; Gu T; Liu H; Liu T; Wei H; Chen H; Zhao J; Yang R; Chen Y; Dong Z; Liu K
Oncogene; 2021 Jun; 40(23):3942-3958. PubMed ID: 33986510
[TBL] [Abstract][Full Text] [Related]
11. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR
Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192
[TBL] [Abstract][Full Text] [Related]
12. AR-42: A Pan-HDAC Inhibitor with Antitumor and Antiangiogenic Activities in Esophageal Squamous Cell Carcinoma.
Zhu Y; Yuan T; Zhang Y; Shi J; Bai L; Duan X; Tong R; Zhong L
Drug Des Devel Ther; 2019; 13():4321-4330. PubMed ID: 31908417
[TBL] [Abstract][Full Text] [Related]
13. Curcumin potentiates the antitumor effects of 5-FU in treatment of esophageal squamous carcinoma cells through downregulating the activation of NF-κB signaling pathway in vitro and in vivo.
Tian F; Fan T; Zhang Y; Jiang Y; Zhang X
Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):847-55. PubMed ID: 23017833
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of Rictor enhances cell sensitivity to PI3K inhibitor LY294002 by blocking mTORC2-medicated phosphorylation of Akt/PRAS40 in esophageal squamous cell carcinoma.
Hou G; Zhao Q; Zhang M; Fan T; Liu M; Shi X; Ren Y; Wang Y; Zhou J; Lu Z
Biomed Pharmacother; 2018 Oct; 106():1348-1356. PubMed ID: 30119206
[TBL] [Abstract][Full Text] [Related]
15. STAT3-EphA7 axis contributes to the progression of esophageal squamous cell carcinoma.
Wang L; Zhao QF; Yang BB; Liang HJ; Zhang XE; Zhang XY; Yang WJ; Guo ZY; Xu X; Tian F; Wu QH
Acta Oncol; 2023 Dec; 62(12):1757-1766. PubMed ID: 37738252
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effect of p65 siRNA and curcumin in promoting apoptosis in esophageal squamous cell carcinoma cells and in nude mice.
Tian F; Zhang C; Tian W; Jiang Y; Zhang X
Oncol Rep; 2012 Jul; 28(1):232-40. PubMed ID: 22552693
[TBL] [Abstract][Full Text] [Related]
17. TOPK promotes metastasis of esophageal squamous cell carcinoma by activating the Src/GSK3β/STAT3 signaling pathway via γ-catenin.
Jiang Y; Zhang J; Zhao J; Li Z; Chen H; Qiao Y; Chen X; Liu K; Dong Z
BMC Cancer; 2019 Dec; 19(1):1264. PubMed ID: 31888532
[TBL] [Abstract][Full Text] [Related]
18. Feed-forward activation of STAT3 signaling limits the efficacy of c-Met inhibitors in esophageal squamous cell carcinoma (ESCC) treatment.
Zhao D; Chen J; Wang Y; Zhang L; Zhang J; Zhang W; Fan J; Li J; Zhan Q
Mol Carcinog; 2021 Jul; 60(7):481-496. PubMed ID: 34018249
[TBL] [Abstract][Full Text] [Related]
19. Germacrone Inhibits Cell Proliferation and Induces Apoptosis in Human Esophageal Squamous Cell Carcinoma Cells.
Zhang R; Hao J; Guo K; Liu W; Yao F; Wu Q; Liu C; Wang Q; Yang X
Biomed Res Int; 2020; 2020():7643248. PubMed ID: 32071920
[TBL] [Abstract][Full Text] [Related]
20. Targeting leucine-rich PPR motif-containing protein/LRPPRC by 5,7,4'-trimethoxyflavone suppresses esophageal squamous cell carcinoma progression.
Liu H; Zhou Y; Fredimoses M; Niu P; Ge Y; Wu R; Liu T; Li P; Shi Y; Shi Y; Liu K; Dong Z
Int J Biol Macromol; 2024 Jun; 269(Pt 1):131966. PubMed ID: 38697422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
